Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 28 ... belief formation in schizophrenia."Freeman and colleagues published their study in Psychopharmacology (Superstitious conditioning as a model of delusion formation ...
2009 NOV 28 ... While the debate over prescription drug advertising persists, a new study released online in the American Journal of Public Health offers guidelines for improving ...
2009 NOV 25 ... announced merger into Ligand. Aplindore This Phase 2 RLS study was a randomized, placebo-controlled, double-blind, multi-center, parallel-group study designed to assess the efficacy, ...
2009 NOV 26 ... in the dietary management of knee osteoarthritis. The 12-week, randomized, double-blind, placebo-controlled trial in an academic medical center enrolled 59 patients with moderate osteoarthritis of ... "This study was designed to determine the safety of a medical food, flavocoxid, a proprietary blend ...
2009 NOV 26 ... its antioxidant effects if consumed on a daily basis by healthy subjects. In this placebo-controlled clinical trial, 63 subjects were recruited for a 1-month nutritional intervention. ... its extract has shown antioxidant and estrogenic activities.""In our study we used S. euboea as an enriching food factor in order to produce a new functional food, ...
2009 NOV 25 ... persist up to 2 years and imp air rehabilitation and reintegration The objective of this study was to determine the effects of long-term treatment with recombinant human growth ...
2009 NOV 29 ... 30 percent of whom were women. Lead investigators of the five double-blinded, randomized placebo-controlled trials shared original study data with authors.Clopidogrel works to disrupt ...
2009 NOV 28 ... aripiprazole (5, 10, or 15 mg/day) or placebo in this 8-week double-blind, randomized, placebo-controlled, parallel-group study.""Efficacy was evaluated using the caregiver-rated ...
2009 NOV 26 ... with the intention of preventing urinary tract infection, but adequately powered, placebo-controlled trials regarding efficacy are lacking. This study from four Australian centers examined ...
2009 NOV 26 ... the amount traditionally used, or placebo for 30 days in a randomized, double-blind, placebo-controlled clinical study in 60 older healthy adults (55-72 years old)," investigators in the ...
2009 NOV 26 ... According to a study from Athens, Greece, "In this randomized, double-blinded, placebo-controlled clinical study we aimed to evaluate the in vivo prebiotic effects of a functional food ...
2009 NOV 23 ... documented inadequate response to triptans for acute MM treatment were included in this placebo-controlled, parallel-group trial." "Women were randomized to double-blind treatment ... reduced MM incidence and severity." Brandes and colleagues published their study in Cephalalgia (Short-term frovatriptan for the prevention of difficult-to-treat ...
2009 NOV 25 ... prospective studies are requires." Tominaga and colleagues published their study in World Journal of Surgery (Surgical and Medical Treatment of Secondary ...
2009 NOV 23 ... to those of the Gail model." Crandall and colleagues published their study in Archives of Internal Medicine (New-Onset Breast Tenderness After Initiation of ...
2009 NOV 23 ... infectious diseases, announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. The two studies, a ... in eighty-four healthy volunteers. The two studies, a single-ascending dose (SAD) study and the multiple-ascending dose (MAD) study, were undertaken to assess the ...
2009 NOV 23 ... effectiveness in preventing syncope. The Prevention of Syncope Trial was a randomized, placebo-controlled, double-blind, multinational, clinical trial that tested the hypothesis that metoprolol ... According to a study from Calgary, Canada, "Beta-Blockers and Quality of Life in Syncope. Vasovagal syncope ...
2009 NOV 23 ... Prev 2009; 18(10):2608-12)." Perkins and colleagues published their study in Cancer Epidemiology Biomarkers & Prevention (Nicotinic Acetylcholine Receptor beta 2 ...
2009 NOV 24 ... or which movie to go see-to the more profound-whether to have kids or not. Now, a new study published online on November 12th in Current Biology, a Cell Press publication, confirms ...
